The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJH.L Regulatory News (MJH)

  • There is currently no data for MJH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Disposal & Cancellation

17 May 2023 11:04

RNS Number : 7486Z
MJ Hudson Group PLC
17 May 2023
 

MJ Hudson Group plc

(the "Company", "Group" or "MJ Hudson")

 

Completion of Sale of Data & Analytics Division,

Cancellation of Admission of Ordinary Shares to Trading on AIM

 

 

MJ Hudson Group plc (AIM:MJH), announces that, further to the announcement on 11 April 2023 in which it confirmed that it had conditionally agreed to sell its Data & Analytics and Business Outsourcing Divisions to Apex, it has now fulfilled the relevant conditions and completed the sale of the Data & Analytics Division.

 

The cash consideration paid on the completion of the sale of the Data & Analytics Division was £15 million of which £3 million is being retained in escrow until 30 September 2024 to satisfy any buyer claims under the sale and purchase agreement.

 

The Business Outsourcing Division which is also being sold to Apex, includes multiple regulated entities which will require certain mandatory and suspensory regulatory consents for a change of ownership. The Business Outsourcing Sale will therefore be completed in stages following receipt or waiver of the regulatory consent(s) relevant to that part of the Business Outsourcing Division. Consideration for the Business Outsourcing Division is approximately £25 million payable in tranches on the completion of the constituent parts of the sale of the Business Outsourcing Division subject to a retention to satisfy any buyer claims under the sale and purchase agreement.

 

Application of Proceeds:

As at 31 March 2023, the Group owed approximately £33.7 million under its facilities and overdrafts with its Senior Lender and it is expected that further funding will be required to the point of completion of the sale of the Business Outsourcing Division.  The majority of the consideration will therefore be applied to reducing the debt owed to the Senior Lender.

 

While there are a number of potential outcomes, given the level of creditors of the business expected at the point of final completion of the Business Outsourcing Sale, it should be noted that it is highly unlikely that there will be a substantial, or any, amount available to Shareholders following payment of all creditors and costs.

 

Cancellation of Admission

In addition, the Company received Shareholders' approval at a General Meeting on 3 May 2023 to cancel the admission of its Ordinary Shares to trading on AIM. In accordance with Rule 41 of the AIM Rules, the Company has notied the London Stock Exchange of the proposed Cancellation and it is expected that Cancellation will occur on 25 May 2023.

 

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 

Completion of the Data & Analytics Sale

16 May 2023

 

Cancellation of the Ordinary Shares from trading on AIM

25 May 2023

 

Completion of the Business Outsourcing Sale

Expected late 2023*

 

*Completion of the Business Outsourcing Sale is expected to complete at various times following the receipt (or waiver) by the Company of the relevant Regulatory Consent(s) relevant to that part of the Business Outsourcing Division.

 

Matched Bargain Facility

 

Following the Cancellation the Ordinary Shares will no longer be admitted to AIM. The Company therefore intends to engage J P Jenkins, the longest established trading platform in UK for unlisted or unquoted companies, to enable shareholders and prospective investors to transact on a matched bargain basis with effect from the date of Cancellation for a limited initial period. However, there can be no certainty that a matched bargain facility will provide a liquid market for the ordinary shares or that it will remain for any extended period following Cancellation, if at all.

 

 

For further information, please contact:

 

MJ Hudson Group plc

Geoff Miller, Executive Chairman

 

Cenkos Securities plc (Nomad and Broker)

Giles Balleny

Stephen Keys

Callum Davidson

+44 20 7397 8900

 

Buchanan (PR Adviser)

Chris Lane

Jack Devoy

George Cleary

+44 20 7466 5000

mjhudson@buchanan.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISBGGDUDGBDGXR
Date   Source Headline
25th May 20237:00 amRNSCancellation - MJ Hudson Group plc
17th May 202311:04 amRNSCompletion of Disposal & Cancellation
4th May 20237:00 amRNSResults of Extraordinary General Meeting
11th Apr 20237:00 amRNSCompany Update
31st Mar 202310:31 amRNSDelay to Publication of Interim Results
10th Mar 20239:00 amRNSSale of UK Fund Management Business
7th Mar 202310:00 amRNSLoan Agreement
24th Feb 20237:33 amRNSLoan Agreement
23rd Feb 202311:07 amRNSDisclosure Regarding Related Party Transactions
15th Feb 20231:18 pmRNSResignation of CEO
13th Feb 20237:00 amRNSResignation of Auditor
16th Jan 20237:00 amRNSCompany and Trading Update
19th Dec 20227:00 amRNSBoard Changes
12th Dec 20227:45 amRNSCompany update and suspension of trading
12th Dec 20227:45 amRNSSuspension - MJ Hudson Group plc
10th Nov 202211:23 amRNSNotification of Major Holdings
10th Nov 20227:00 amRNSSIP and PDMR Dealings
4th Nov 20227:29 amRNSESG Business Expansion
1st Nov 20227:00 amRNSDirectorate Change
1st Nov 20227:00 amRNSChange in role of Non-Executive Chairman
17th Oct 20224:40 pmRNSSecond Price Monitoring Extn
17th Oct 20224:36 pmRNSPrice Monitoring Extension
17th Oct 20222:06 pmRNSSecon Price Monitoring Extn
17th Oct 20222:06 pmRNSSecond Price Monitoring Extn
17th Oct 20222:01 pmRNSPrice Monitoring Extension
17th Oct 20222:01 pmRNSPrice Monitoring Extension
17th Oct 202211:05 amRNSSecond Price Monitoring Extn
17th Oct 202211:00 amRNSPrice Monitoring Extension
17th Oct 202211:00 amRNSPrice Monitoring Extension
17th Oct 202210:06 amRNSSecon Price Monitoring Extn
17th Oct 20229:05 amRNSSecond Price Monitoring Extn
17th Oct 20229:00 amRNSPrice Monitoring Extension
17th Oct 20229:00 amRNSPrice Monitoring Extension
17th Oct 20227:00 amRNSChanges to guiance following auit ajustments
17th Oct 20227:00 amRNSChanges to guidance following audit adjustments
11th Oct 20227:00 amRNSSIP and PDMR Dealings
9th Sep 20223:31 pmRNSSIP and PDMR Dealings
1st Sep 20224:00 pmRNSNotification of Major Holdings
1st Sep 20221:10 pmRNSPDMR Dealings
31st Aug 20223:21 pmRNSResults of General Meeting and Issue of Equity
19th Aug 20224:20 pmRNSDirector’s Share Transfer
17th Aug 20227:00 amRNSInvestor Presentation
11th Aug 20227:00 amRNSResults of Placing and Retail Offer
10th Aug 20224:54 pmRNSRetail Offer
10th Aug 20224:41 pmRNSProposed Fundraise
9th Aug 20224:36 pmRNSSIP and PDMR Dealings
12th Jul 20227:00 amRNSSIP and PDMR Dealings
12th Jul 20227:00 amRNSTrading Update – Ahead of Expectations
14th Jun 20227:00 amRNSStrategic Partnership With Cork Gully
10th Jun 20226:01 pmRNSSIP and PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.